renal cancer
Conditions
Interventions
cryoablation
radiofrequency ablation
Sponsors
Kochi University, Kochi Medical School
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Cases of renal cancer less than 3 cm in length First treated lesions (however, lesions that have recurred in a different site in the same patient may be included in the study) Patients undergoing percutaneous ablation treatment for small diameter renal tumors at Kochi Medical School Hospital between after Ethics Committee approval and 2026.3
Exclusion criteria
Exclusion criteria: Cases which are considered not indication of radiofrequency ablation or cryotherapy at the conference before therapy, etc. Cases in which the patient's consent cannot be obtained Cases in which the target lesion has been treated with chemotherapy, molecular targeting, radiotherapy, surgery or other concomitant therapies for one month prior to and during the treatment period (excluding folk therapies that are not based on scientific evidence)
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| CT or MRI scans are performed before and periodically for two years after treatment to determine the effectiveness of treatment. Dynamic examinations using contrast media should be performed whenever possible, unless there are problems such as allergies or renal impairment. | — |
Secondary
| Measure | Time frame |
|---|---|
| Pre- and post-operative assessment of renal function, inflammatory response, pain, blood pressure and neurological symptoms, etc at regular intervals | — |
Countries
Japan
Contacts
Public ContactTAKUJI YAMAGAMI
Kochi University, Kochi Medical School Department of Diagnostic and Interventional Radiology
Outcome results
None listed